| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 40.82 | 1.70 | +4.35% |
| Virtus Biotech Clinical Trials ETF (BBC) | |||
| PMMY | 27.21 | 0.03 | +0.13% |
| PGIM S&P 500 Max Buffer ETF - May (PMMY) | |||
| NULV | 53.72 | -0.16 | -0.30% |
| Nuveen ESG Large-Cap Value ETF (NULV) | |||
| SMCO | 27.62 | -0.10 | -0.35% |
| Hilton Small-MidCap Opportunity ETF (SMCO) | |||
| JRI | 10.50 | -0.06 | -0.57% |
| NUVEEN REAL ASSET Income AND GROWTH FUND | |||
A.I.dvisor indicates that over the last year, SBIO has been closely correlated with XBI. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if SBIO jumps, then XBI could also see price increases.
| Ticker / NAME | Correlation To SBIO | 1D Price Change % | ||
|---|---|---|---|---|
| SBIO | 100% | +3.97% | ||
| XBI - SBIO | 94% Closely correlated | +2.45% | ||
| VHT - SBIO | 52% Loosely correlated | -0.37% | ||
| IHI - SBIO | 49% Loosely correlated | +0.04% | ||
| IXJ - SBIO | 45% Loosely correlated | -0.47% | ||
| XLV - SBIO | 39% Loosely correlated | -0.60% | ||
More | ||||
Category Health
The Aroon Indicator for SBIO entered a downward trend on October 19, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 208 similar instances where the Aroon Indicator formed such a pattern. In 187 of the 208 cases the stock moved lower. This puts the odds of a downward move at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SBIO's RSI Oscillator exited the oversold zone, 25 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
Following a +0.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where SBIO advanced for three days, in 284 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
SBIO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.